Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Classifica tra le azioni #27020
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Prezzo delle azioni
$0.16240909
Ultima sincronizzazione: 2025-03-04
Capitalizzazione di mercato
$35.68M
Variazione (1 giorno)
0.27%
Variazione (1 anno)
0.00%
Paese
CN
Scambia Dali Pharmaceuticalco.,Ltd (603963)

Categoria

Storico del rendimento da dividendi per Dali Pharmaceuticalco.,Ltd (603963)
Il rendimento da dividendi (TTM) di Dali Pharmaceuticalco.,Ltd (simbolo azionario: 603963) al 2022-12-31 è: 0.08%
Rendimento medio negli ultimi 5 anni: 0.24%
Storico del rendimento da dividendi per Dali Pharmaceuticalco.,Ltd (603963) da 2012 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
2026 (TTM) 0.00% -100.00%
2023 0.06% -25.00%
2022 0.08% -84.62%
2021 0.52% 1,633.33%
2020 0.03% -94.23%
2019 0.52% -21.21%
2018 0.66% -76.00%
2017 2.75% -59.80%
2016 6.84% -18.18%
2015 8.36% -14.69%
2014 9.80% 15.70%
2013 8.47% 9,311.11%
2012 0.09% 0.00%
Rendimenti da dividendi (TTM) di aziende simili o concorrenti